Skip to main content
SpringerLink
Log in

Authors’ Response to Braillon’s Comment on: “Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring”

  • Letter to the Editor
  • Published:
Drug Safety Aims and scope Submit manuscript

The Original Article was published on 17 August 2018

The Original Article was published on 17 August 2018

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Simoons M, Seldenrijk A, Mulder H, Birkenhager T, Groothedde-Kuyvenhoven M, Kok R, et al. Limited evidence for risk factors for proarrhythmia and sudden cardiac death in patients using antidepressants: Dutch Consensus on ECG Monitoring. Drug Saf. 2018;41:655–64.

    Article  CAS  Google Scholar 

  2. Braillon A. Comment on: “Limited evidence for risk factors for proarrhythmia and sudden cardiac death in patients using antidepressants: Dutch Consensus on ECG Monitoring”. Drug Saf. 2018. https://doi.org/10.1007/s40264-018-0714-7.

    Article  PubMed  Google Scholar 

  3. Spijker J, Bockting CLH, Meeuwissen JAC, Vliet van IM, Emmelkamp PMG, Hermens MLM, et al. Multidisciplinary guideline depression (third revision) [in Dutch]. 2013. https://www.ggzrichtlijnen.nl/depressie. Accessed 19 Jul 2018.

  4. National Institute for Health and Care Excellence. Depression in adults: recognition and management (CG 90). 2009. https://www.nice.org.uk/guidance/cg90. Accessed 19 Jul 2018.

  5. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 2010. http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf. Accessed 19 Jul 2018.

  6. Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF 3rd. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry. 2014;13:56–67.

    Article  Google Scholar 

  7. Prescrire. Towards better patient care: drugs to avoid in 2017. Rev Prescrire. 2017;37:137–48.

    Google Scholar 

  8. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357–66.

    Article  CAS  Google Scholar 

  9. Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012;69:580–7.

    Article  CAS  Google Scholar 

  10. Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes a, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, The Netherlands

    Mirjam Simoons & Hans Mulder

  2. Department of Psychiatry, Radboudumc, PO-Box 9101, 6500 HB, Nijmegen, The Netherlands

    Mirjam Simoons, Adrie Seldenrijk & Henricus Ruhé

  3. Unit of Pharmacotherapy, Epidemiology and-Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands

    Mirjam Simoons & Eric van Roon

  4. Department of Research and Innovation, GGZ InGeest, Amsterdam, The Netherlands

    Adrie Seldenrijk

  5. Psychiatric Hospital GGZ Drenthe, Assen, The Netherlands

    Hans Mulder

  6. Department of Clinical Pharmacy and Clinical Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands

    Eric van Roon

  7. Psychiatric Centre GGz Centraal, Amersfoort, The Netherlands

    Roberto Bakker

  8. Department of Psychiatry and Psychology, South Limburg Mental Health and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands

    Roberto Bakker

  9. Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK

    Henricus Ruhé

  10. Department of Psychiatry, Radboudumc, Nijmegen, The Netherlands

    Henricus Ruhé

Authors
  1. Mirjam Simoons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrie Seldenrijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric van Roon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto Bakker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Henricus Ruhé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henricus Ruhé.

Ethics declarations

Funding

No specific funding was received for this letter. The original project was funded by the Dutch Network for Quality Development in Mental Health Care (Grants P140019 and P140040 to Henricus Ruhé and Roberto Bakker). This organization had no influence on the content of the study, the original manuscript, or this letter.

Conflict of interest

Henricus Ruhé obtained an Investigator-Initiated Trial grant and speaking fees from Lundbeck BV, which are not related to the current work. Mirjam Simoons, Adrie Seldenrijk, Hans Mulder, Eric van Roon, and Roberto Bakker have no conflicts of interest that are directly relevant to the contents of the study, the original manuscript, or this letter.

Ethics approval

Ethics approval was not applicable for this letter.

Patient consent

Patient consent was not applicable for this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simoons, M., Seldenrijk, A., Mulder, H. et al. Authors’ Response to Braillon’s Comment on: “Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring”. Drug Saf 41, 1417–1418 (2018). https://doi.org/10.1007/s40264-018-0716-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-018-0716-5

Search

Navigation